|
25 Aug 2020
|
Lasa Supergenerics
|
Khambatta Securities
|
12.04
|
84.00
|
63.80
(-81.13%)
|
Target met |
Buy
|
|
|
Increasing prevalence of zoonotic diseases will drive demand for veterinary API products globally. Increasing awareness about preventive animal healthcare and judicious...
|
|
04 Jun 2018
|
Lasa Supergenerics
|
Joindre Capital Services
|
12.04
|
55.00
|
51.90
(-76.80%)
|
|
Hold
|
|
|
Lasa Supergenerics is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chainfrom discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity For FY18 the company has reported a PAT of Rs 12.32 crs as compared to Rs 2.35 crs last year on a Topline of Rs 249 crs from Rs 220 crs last year. Operating EBIDTA in FY18 totalled Rs 41 crs as compared to Rs 18 crs recorded last year....
|
|
14 Dec 2017
|
Lasa Supergenerics
|
Joindre Capital Services
|
12.04
|
225.00
|
134.90
(-91.07%)
|
|
Buy
|
|
|
Lasa Supergenerics Limited (Lasa) is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chain from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity, which was acquired in April 2012. for around Rs 6 crs. OSCL acquired Lasa as a part of forward integration for some of its chemicals. From a revenue base of less than 10 crs before acquisition, Lasa has reached revenue of Rs 200 crs now The manufacturing base of Lasa is located at Mahad, in the Konkan region of Maharashtra. It specialises in...
|